Actelion has operative affiliates in over 30 countries - explore our global operations.
The overarching principle of Actelion’s Corporate Social Responsibility reflects the company’s mission to treating more patients with innovative medicines.
We see Corporate Governance as the underpinning foundation for maximising value creation for our shareholders.
On 21 July 2015 Actelion published the Half-year 2015 financial results accompanied by the publication of the company's Half-year Report.
Please note that product information contained on this website may not necessarily comply with local product information. You are solely responsible to obtain country specific documentation.
Imprint | Legal & privacy statement | Webmaster
Copyright © 2016 Actelion Pharmaceuticals Ltd
To access local information please visit one of our affiliate sites: